In this issue:
International consensus definition for GPP
Epidemiology, characteristics, and unmet need in GPP
Self-assessment vs physician-assessed severity of psoriasis
Bimekizumab safety in moderate-to-severe plaque psoriasis
Skin cancer risk with methotrexate and NB-UVB
Clinical course of GPP in Portugal
Nail psoriasis treated with biologics
Ustekinumab biosimilar in moderate-to-severe plaque psoriasis
Please login below to download this issue (PDF)